News
Investment
Research
Lifestyle
Search for:
Search
More
About us
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
Investment
World’s first Rejuvenation Startup Summit is announced
Investment
Juvenescence and Buck Institute launch company to target heart disease
Investment
Oviva Therapeutics raises $11.5m seed and bags exclusive licensing
Oviva announces seed financing and exclusive licence with Massachusetts General to develop therapeutics to extend healthspan in women.
Investment
Tech founders rally into Ultrahuman funding round
Investment
Artificial heart developer CARMAT beats €40.5 million funding goal
Investment
Kizoo portfolio company Elastrin Therapeutics closes $10 million funding round
Investment
Fauna Bio partners with UW Oshkosh in search for novel therapies for disease
Investment
Rejuvenate Biomed starts groundbreaking sarcopenia trial with eye on future growth
Investment
Genflow collaborates with Aging Research Centre to drive sirtuin research
Investment
Strategic partnership plans disruptive, personalised AI engine to counter skin aging
Investment
Moon Rabbit partners with Foresight to accelerate longevity ideas into reality
Investment
Juvenescence targets fibrotic disease with new investment
Investment
Revel announces $8.4m for repairing-based approaches to reversing aging
Investment
Genflow receives grant award to accelerate longevity research
Investment
New partnership set to use AI to accelerate regenerative medicine
Investment
NIH and DoD-backed Ridgeline targets muscle decline
Investment
International Women’s Day: the wonderful women of longevity
Investment
Exogenus and Boehringer Ingelheim in regenerative medicine collaboration
Investment
Life insurance epigenetics start-up Foxo plans IPO via SPAC
Investment
New innovation longevity research prize launched
Investment
The state of longevity – clinical trials progress gathers pace
Investment
Crunching the longevity numbers – 2021 investment shows the market is booming
Investment
Apollo partners with VitaDAO and Molecule on Web3 for longevity biotech
Investment
Next gen rapalogs – Cambrian Biopharma announces mTOR inhibitors licensing agreement
Investment
Building new oncology therapeutics with longevity potential
Investment
Rosita Longevity over 60s health app launches in US
Investment
Johnson & Johnson bags rapamycin analog biotech Anakuria
Investment
Cellino bags $80 million to autonomise stem cell therapy manufacturing
Investment
NURO embarks on funding round for neurotech communication system
Investment
Mental illness drug discovery company Neurai Life Sciences launches
Investment
Altos Labs lands $3 billion to further cellular rejuvenation programming
Investment
StarkAge secures 2 million euros for senescence targeting therapy
Investment
Load More